FMR1 and fragile X syndrome: Early studies that generated iPSCs derived from primary cells of patients with FXS (hereafter referred to as FXS-iPSCs) found that FMR1 was inactive in iPSCs and its expression was not reactivated by reprograming the original somatic cells into iPSCs [46,47], nor by differentiation into neurons [47] (Figure 1A).